Emedgene, a startup that employs artificial intelligence to interpret genetic data, has closed a $6 million round led by OliveTree Ventures.
What they do
Trained using data from patient cases, publications and genomics databases, Emedgene’s decision support engine can identify and highlight clinically relevant genetic variants for the provider. The platform is supported by a digital workbench...
